Lexeo Therapeutics (LXEO)'s 30-day implied volatility (IV30) was 114.8% at the close on November 13, 2026, up from 88.7% the day before, against a 52-week range of 50.0% to 275.0%. Its 20-day historical volatility was 104.3%.
Data as of November 13, 2026.